Literature DB >> 10656034

The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides.

W Peters1, B L Robinson.   

Abstract

Chloroquine-sensitive Plasmodium berghei N and chloroquine-resistant P. yoelii ssp. NS were exposed to selection pressure, in the '2% relapse technique', from artemisinin, artesunate, a bicyclic, synthetic endoperoxide Ro 41-3823 (an analogue of arteflene) or Fenozan B07, a synthetic 1,2,4-trioxane endoperoxide. Whereas resistance against artemisinin did develop to a moderate level in both parasites, only a low level of resistance or none developed to the other compounds, and resistant parasites readily lost resistance once drug-selection pressure was withdrawn. The relevance of these observations and the experience of other investigators are discussed in relation to the possible risk that resistance may be developed in nature once endoperoxides are deployed widely against multidrug-resistant P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10656034     DOI: 10.1080/00034989958320

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  11 in total

1.  Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii.

Authors:  D J Walker; J L Pitsch; M M Peng; B L Robinson; W Peters; J Bhisutthibhan; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Selection and reversal of Plasmodium berghei resistance in the mouse model following repeated high doses of artemether.

Authors:  Shu-Hua Xiao; Jun-Min Yao; Jürg Utzinger; Yue Cai; Jacques Chollet; Marcel Tanner
Journal:  Parasitol Res       Date:  2003-12-16       Impact factor: 2.289

3.  Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.

Authors:  Philipp P Henrich; Connor O'Brien; Fabián E Sáenz; Serge Cremers; Dennis E Kyle; David A Fidock
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

4.  Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10.

Authors:  A Afonso; P Hunt; S Cheesman; A C Alves; C V Cunha; V do Rosário; P Cravo
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Resistance of a rodent malaria parasite to a thymidylate synthase inhibitor induces an apoptotic parasite death and imposes a huge cost of fitness.

Authors:  Francis W Muregi; Isao Ohta; Uchijima Masato; Hideto Kino; Akira Ishih
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

6.  Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites.

Authors:  Laura C Pollitt; Silvie Huijben; Derek G Sim; Rahel M Salathé; Matthew J Jones; Andrew F Read
Journal:  PLoS Pathog       Date:  2014-04-24       Impact factor: 6.823

7.  Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.

Authors:  Winnie R Gimode; Daniel M Kiboi; Francis T Kimani; Hannah N Wamakima; Marion W Burugu; Francis W Muregi
Journal:  Malar J       Date:  2015-01-28       Impact factor: 2.979

Review 8.  Application of multi-target phytotherapeutic concept in malaria drug discovery: a systems biology approach in biomarker identification.

Authors:  Protus Arrey Tarkang; Regina Appiah-Opong; Michael F Ofori; Lawrence S Ayong; Alexander K Nyarko
Journal:  Biomark Res       Date:  2016-12-13

Review 9.  Biological actions of artemisinin: insights from medicinal chemistry studies.

Authors:  Jian Li; Bing Zhou
Journal:  Molecules       Date:  2010-03-08       Impact factor: 4.411

10.  Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.

Authors:  D M Kiboi; B N Irungu; B Langat; S Wittlin; R Brun; J Chollet; O Abiodun; J K Nganga; V C S Nyambati; G M Rukunga; A Bell; A Nzila
Journal:  Exp Parasitol       Date:  2009-03-24       Impact factor: 2.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.